Optimal dosing of medications (in bipolar disorder).
Maguire
Gerald A
GA
Department of Psychiatry, University of California, Irvine, College of Medicine, USA.
Phillips
Geoffrey
G
D000208:Acute Disease; D000339:Affect / Q000187:drug effects; D018692:Antimanic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001569:Benzodiazepines; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000523:psychology*; D002908:Chronic Disease; D004334:Drug Administration Schedule; D006801:Humans; D018020:Lithium Compounds / Q000008:administration & dosage; D000077152:Olanzapine; D010890:Pirenzepine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016896:Treatment Outcome; D014635:Valproic Acid / Q000008:administration & dosage
D018692:Antimanic Agents; D014150:Antipsychotic Agents; D018020:Lithium Compounds; D001569:Benzodiazepines; D010890:Pirenzepine; D014635:Valproic Acid; D000077152:Olanzapine